These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34045815)

  • 1. Multiple Peaked Cytokine Storm: Is Multiple Exposures to the COVID-19 Virus a Possible Cause?
    Kumar A; Kumar A; Kumar A; Kumar N; Sinha C; Singh V
    Indian J Crit Care Med; 2021 Apr; 25(4):463-464. PubMed ID: 34045815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
    Mehta Y; Dixit SB; Zirpe KG; Ansari AS
    Indian J Crit Care Med; 2020 Jun; 24(6):429-434. PubMed ID: 32863636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label Use of Itolizumab in Patients with COVID-19 ARDS: Our Clinical Experience in a Dedicated COVID Center.
    Kumari P; Kumar A; Sinha C; Kumar A; Singh PK; Arun SK
    Indian J Crit Care Med; 2021 Apr; 25(4):467-469. PubMed ID: 34045817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Oxygen Therapy in COVID-19 Patient: A Method to Improve Oxygenation.
    Kumar A; Kumar A; Sinha C; Kumar N; Singh K; Singh PK
    Indian J Crit Care Med; 2021 Feb; 25(2):231-233. PubMed ID: 33707906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Storm and Immunomodulation in COVID-19.
    Rangappa P
    Indian J Crit Care Med; 2021 Nov; 25(11):1288-1291. PubMed ID: 34866828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Long-term Oxygen Therapy and Noninvasive Ventilation Predispose Rhino-orbital-cerebral Mucormycosis in COVID-19 Patients?
    Kumar A; Kumar A; Kumar N; Kumar A; Sinha C; Singh PK
    Indian J Crit Care Med; 2022 Sep; 26(9):1063-1064. PubMed ID: 36213719
    [No Abstract]   [Full Text] [Related]  

  • 7. Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers.
    Nasa P; Singh A; Upadhyay S; Bagadia S; Polumuru S; Shrivastava PK; Sankar R; Vijayan L; Soliman MA; Ali A; Patidar S
    Indian J Crit Care Med; 2020 Sep; 24(9):771-776. PubMed ID: 33132558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
    Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
    Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Exacerbation of Cough as a Precipitating Cause of Hypoxia in COVID-19 Patients.
    Kumar A; Kumar A; Kumar A; Sinha C; Kumar N; Singh PK
    Indian J Crit Care Med; 2021 Nov; 25(11):1324-1325. PubMed ID: 34866836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
    Ciampa ML; O'Hara TA; Joel CL; Gleaton MM; Tiwari KK; Boudreaux DM; Prasad BM
    Infect Dis Rep; 2021 Apr; 13(2):377-387. PubMed ID: 33921604
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe COVID-19 along with Cytokine Storm in Pemphigus Vulgaris Managed Successfully with Dexamethasone Pulse Therapy.
    Pradhan S; Kumar N; Kumar S
    Indian J Crit Care Med; 2021 Nov; 25(11):1320-1321. PubMed ID: 34866834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
    Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig JC; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    medRxiv; 2020 Aug; ():. PubMed ID: 32869036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytokine storm in coronavirus infections: culprit or accomplice?
    Xu R; Liu C; Xu X; Hu Y; Zhu B; Yang C
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):102. PubMed ID: 35345334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
    Machado C; González-Quevedo A
    MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.